2614 Stock Overview
Researches, develops, manufactures, and sells health massage appliances in China and internationally.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 3/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 5/6 |
Xiamen Comfort Science&Technology Group Co., Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥5.78 |
52 Week High | CN¥9.20 |
52 Week Low | CN¥5.19 |
Beta | 0.40 |
11 Month Change | -15.74% |
3 Month Change | -21.04% |
1 Year Change | -23.55% |
33 Year Change | -75.14% |
5 Year Change | -64.25% |
Change since IPO | -63.69% |
Recent News & Updates
Recent updates
Shareholder Returns
2614 | CN Leisure | CN Market | |
---|---|---|---|
7D | -2.2% | -1.3% | -0.7% |
1Y | -23.5% | -28.0% | -14.6% |
Return vs Industry: 002614 exceeded the CN Leisure industry which returned -28% over the past year.
Return vs Market: 002614 underperformed the CN Market which returned -14.6% over the past year.
Price Volatility
2614 volatility | |
---|---|
2614 Average Weekly Movement | 3.9% |
Leisure Industry Average Movement | 6.7% |
Market Average Movement | 6.7% |
10% most volatile stocks in CN Market | 10.1% |
10% least volatile stocks in CN Market | 4.1% |
Stable Share Price: 002614's share price has been volatile over the past 3 months.
Volatility Over Time: 002614's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1996 | 8,189 | Jianhan Zou | www.easepal.com.cn |
Xiamen Comfort Science&Technology Group Co., Ltd researches, develops, manufactures, and sells health massage appliances in China and internationally. The company offers massage chairs and appliances; fresh air systems and air purifiers; weight analysis scales; and other products. It offers its products under the BRI, medisana, SHUSIJIA, ETRO, joypal, EASEWELL, FUJIMEDIC, ihoco, FUJI, cozzia, and OGAWA brands.
Xiamen Comfort Science&Technology Group Co., Ltd Fundamentals Summary
2614 fundamental statistics | |
---|---|
Market cap | CN¥3.60b |
Earnings (TTM) | CN¥89.04m |
Revenue (TTM) | CN¥4.90b |
39.3x
P/E Ratio0.7x
P/S RatioIs 2614 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
2614 income statement (TTM) | |
---|---|
Revenue | CN¥4.90b |
Cost of Revenue | CN¥3.13b |
Gross Profit | CN¥1.77b |
Other Expenses | CN¥1.68b |
Earnings | CN¥89.04m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.14 |
Gross Margin | 36.16% |
Net Profit Margin | 1.82% |
Debt/Equity Ratio | 34.4% |
How did 2614 perform over the long term?
See historical performance and comparison